Diatranz Otsuka's Corporate Minority Round

Diatranz Otsuka raised a round of funding on January 01, 2011. Investors include Otsuka Holdings.

Diatranz Otsuka uses the biological similarities between humans and other mammals to develop cellular therapies to improve the lives of people living with serious diseases.…

Articles about Diatranz Otsuka's Corporate Minority Round: